Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Given Average Recommendation of "Buy" by Brokerages : vimarsana.com

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) has earned an average rating of “Buy” from the twelve analysts that are covering the company, MarketBeat.com reports. Twelve research analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is […]

Related Keywords

John Militello , William Blair , Pura Vida Investments , Analyst Recommendations For Rocket Pharmaceuticals , Synovus Financial Corp , Rocket Pharmaceuticals Inc , News Ratings For Rocket Pharmaceuticals Daily , Rocket Pharmaceuticals Stock Down , Rocket Pharmaceuticals , Needham Company , Privium Fund Management , Nasdaq , Free Report , Chardan Capital , Vida Investments , Financial Corp , Pharmaceuticals Stock Down , Rocket Pharmaceuticals Daily , Nasdaq Rckt , Rckt , Medical , Ratings , Consensus ,